Keymed Biosciences Inc.(Stock Code: 02162 HK) focuses on the urgent unmet clinical needs, and is committed to providing high-quality, affordable, innovative therapies for patients in China and overseas.
Keymed Biosciences Inc.(Stock Code: 02162 HK) focuses on the urgent unmet clinical needs, and is committed to providing high-quality, affordable, innovative therapies for patients in China and overseas.
30+
在研项目
7+
临床阶段项目
3+
双特异性抗体
1+
抗体偶联药物
Company Profile Management Team Milestones
R&D Center Pipeline Manufacturing Park Cooperation
Corporate Governance Information Disclosure Financial Reports Stock Information IR Calendar Investor Presentations Email Alerts IR Contact
Latest News Media
Culture & Benefits
Contact Information Consultation Legal Statement Privacy
Tel:028-88610620
Email:pr@keymedbio.com/BD@keymedbio.com
蜀ICP备2022006281号